Hot Blue Chip Stocks To Watch For 2019

Inverness Counsel LLC NY trimmed its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 3.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 222,754 shares of the healthcare conglomerate’s stock after selling 7,191 shares during the quarter. UnitedHealth Group comprises 3.1% of Inverness Counsel LLC NY’s investment portfolio, making the stock its 6th biggest holding. Inverness Counsel LLC NY’s holdings in UnitedHealth Group were worth $54,650,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Welch Group LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $106,000. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $107,000. Bamco Inc. NY acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $117,000. Northwest Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $117,000. Finally, Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $134,000. 85.17% of the stock is owned by institutional investors.

Hot Blue Chip Stocks To Watch For 2019: NTN Buzztime, Inc.(NTN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Pacific Ethanol alerts:

    Price to Earnings Ratio in the Spotlight – Pacific Ethanol Inc (NASDAQ: PEIX) (stocksmarketcap.com) Where Relative Volume Stands? – Pacific Ethanol Inc (NASDAQ: PEIX) (stockspen.com) Hot Stock’s Trend Recap – Pacific Ethanol Inc. (NASDAQ: PEIX) (financerater.com) Global Biorefinery Market 2018 Outlook and Growth by 2023: Pacific Ethanol, Renewable Energy Group Inc, Abengoa … (thecleantechnology.com) Volume Movers: Jones Energy, Inc. (NYSE:JONE), Pacific Ethanol, Inc. (NASDAQ:PEIX), NTN Buzztime, Inc. (NYSE:NTN) (stocksnewspoint.com)

    NASDAQ PEIX traded down $0.05 during trading hours on Thursday, reaching $3.10. The company’s stock had a trading volume of 201,540 shares, compared to its average volume of 407,376. The stock has a market capitalization of $141.29 million, a price-to-earnings ratio of -3.65 and a beta of 2.03. Pacific Ethanol has a 1-year low of $2.75 and a 1-year high of $7.50. The company has a current ratio of 2.24, a quick ratio of 1.51 and a debt-to-equity ratio of 0.61.

Hot Blue Chip Stocks To Watch For 2019: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Verde Servicos Internacionais S.A. reduced its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 12.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 8,922 shares of the biopharmaceutical company’s stock after selling 1,315 shares during the period. Verde Servicos Internacionais S.A.’s holdings in FibroGen were worth $558,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    FibroGen (NASDAQ:FGEN) was upgraded by analysts at ValuEngine from a buy rating to a strong-buy rating.

    Fulgent Genetics (NASDAQ:FLGT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.25 price target on the stock. According to Zacks, “Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company’s technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics, Inc. is headquartered in Temple City, California. “

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on FibroGen (FGEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Hilltop Holdings Inc. lifted its holdings in shares of FibroGen Inc (NASDAQ:FGEN) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 55,140 shares of the biopharmaceutical company’s stock after buying an additional 1,530 shares during the period. FibroGen makes up approximately 0.7% of Hilltop Holdings Inc.’s holdings, making the stock its 22nd largest position. Hilltop Holdings Inc. owned approximately 0.07% of FibroGen worth $3,452,000 as of its most recent filing with the SEC.

Hot Blue Chip Stocks To Watch For 2019: Seacoast Banking Corporation of Florida(SBCF)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Seacoast Banking Co. of Florida (SBCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Seacoast Banking Co. of Florida (SBCF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    BidaskClub cut shares of Seacoast Banking Co. of Florida (NASDAQ:SBCF) from a hold rating to a sell rating in a research note released on Wednesday.

  • [By Max Byerly]

    Media headlines about Seacoast Banking Co. of Florida (NASDAQ:SBCF) have trended somewhat positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Seacoast Banking Co. of Florida earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6820292106654 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Blue Chip Stocks To Watch For 2019: Alpine Total Dynamic Dividend Fund(AOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer & Co. Inc. lifted its stake in shares of Alpine Total Dynamic Div (NYSE:AOD) by 14.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,451 shares of the investment management company’s stock after acquiring an additional 12,551 shares during the period. Oppenheimer & Co. Inc. owned 0.09% of Alpine Total Dynamic Div worth $906,000 as of its most recent SEC filing.

Hot Blue Chip Stocks To Watch For 2019: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Globus Medical Inc  (NYSE:GMED)Q4 2018 Earnings Conference CallFeb. 21, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

  • [By Joseph Griffin]

    Hill-Rom (NYSE:HRC) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

  • [By Logan Wallace]

    Penumbra (NYSE: PEN) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitability and valuation.

  • [By Ethan Ryder]

    Northern Trust Corp raised its holdings in shares of Globus Medical Inc (NYSE:GMED) by 2.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,190,383 shares of the medical device company’s stock after acquiring an additional 33,264 shares during the quarter. Northern Trust Corp’s holdings in Globus Medical were worth $60,067,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Several analysts have issued reports on GMED shares. Morgan Stanley lowered shares of Globus Medical from an overweight rating to an equal weight rating and decreased their price target for the stock from $64.00 to $49.00 in a research report on Wednesday, January 2nd. ValuEngine lowered shares of Globus Medical from a strong-buy rating to a buy rating in a research report on Wednesday, November 28th. Cantor Fitzgerald set a $60.00 price target on shares of Globus Medical and gave the stock a buy rating in a research report on Friday, January 18th. Zacks Investment Research lowered shares of Globus Medical from a buy rating to a hold rating in a research report on Tuesday, January 8th. Finally, UBS Group began coverage on shares of Globus Medical in a research report on Wednesday, November 28th. They set a neutral rating and a $55.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $56.08.

    TRADEMARK VIOLATION NOTICE: “Globus Medical (GMED) Releases FY 2019 Earnings Guidance” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/4169557/globus-medical-gmed-releases-fy-2019-earnings-guidance.html.

    Globus Medical Company Profile

Leave a Reply

Your email address will not be published. Required fields are marked *